Search for Clinical Trial Results

Sponsored By

Hurthle Cell Thyroid Cancer - 6 Studies Found

Status Study
Recruiting Study Name: Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Condition: Refractory Hurthle Cell Thyroid Cancer
Date: 2014-05-19
Interventions:
  • Drug: sorafenib Given PO
Completed Study Name: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
Condition:
  • Papillary Thyroid Cancer
  • Follicular Thyroid Cancer
  • Date: 2010-03-22
    Interventions:
    • Drug: rosiglitazone one 4 mg d
Recruiting Study Name: Studies on Tumors of the Thyroid
Condition:
  • Hurthle Cell Thyroid Cancer
  • Tall Cell Variant Thyroid Cancer Date: 1999-11-03
Completed Study Name: Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Condition:
  • Malignant Struma Ovarii
  • Papillary Thyroid Cancer
  • Date: 2011-09-24
Recruiting Study Name: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Date: 2011-07-06
Interventions: Radiation: I131 1.1 GBq Radio-iodine Other Name: Sod
Completed Study Name: A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
Condition: Thyroid Cancer
Date: 2005-07-12
Interventions: Drug: AMG 706